Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 07:46 am Sale | 2021-12-31 | 13G | Eli Lilly and Company LLY | PNC FINANCIAL SERVICES GROUP INC. PNC | 51,888,455 5.420% | -123,696 (-0.24%) | Filing History |
| 2022-02-10 4:29 pm Purchase | 2021-12-31 | 13G | Forma Therapeutics Holdings, Inc. FMTX | ELI LILLY & Co LLY | 339,191 0.700% | 339,191 (New Position) | Filing History |
| 2022-02-10 4:26 pm Purchase | 2021-12-31 | 13G | Surface Oncology, Inc. SURF | ELI LILLY & Co LLY | 1,593,997 3.500% | 1,593,997 (New Position) | Filing History |
| 2022-02-10 4:21 pm Unchanged | 2021-12-31 | 13G | Avidity Biosciences, Inc. RNA | ELI LILLY & Co LLY | 2,319,396 4.900% | 0 (Unchanged) | Filing History |
| 2022-02-10 4:16 pm Purchase | 2021-12-31 | 13G | Avidity Biosciences, Inc. RNA | ELI LILLY & Co LLY | 3,151,605 3.500% | 3,151,605 (New Position) | Filing History |
| 2022-02-10 4:13 pm Purchase | 2021-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE | ELI LILLY & Co LLY | 61,061 3.100% | 61,061 (New Position) | Filing History |
| 2022-02-10 4:05 pm Purchase | 2021-12-31 | 13G | Immunocore Holdings plc IMCR | ELI LILLY & Co LLY | 2,548,145 5.800% | 2,548,145 (New Position) | Filing History |
| 2022-02-09 3:43 pm Purchase | 2021-12-31 | 13G | Eli Lilly and Company LLY | The Vanguard Group | 69,261,754 7.240% | 600,260 (+0.87%) | Filing History |
| 2022-02-08 5:12 pm Purchase | 2021-12-31 | 13G | Eli Lilly and Company LLY | BlackRock Inc. BLK | 63,877,023 6.700% | 5,065,255 (+8.61%) | Filing History |
| 2022-01-27 4:56 pm Sale | 2021-12-31 | 13G | Eli Lilly and Company LLY | LILLY ENDOWMENT INC | 107,463,810 11.230% | -3,668,533 (-3.30%) | Filing History |
| 2021-12-13 08:16 am Purchase | 2021-12-10 | 13G | Foghorn Therapeutics Inc. FHTX | ELI LILLY & Co LLY | 4,000,000 9.700% | 4,000,000 (New Position) | Filing History |
| 2021-09-10 1:03 pm Purchase | 2021-09-03 | 13G | ProQR Therapeutics N.V. PRQR | ELI LILLY & Co LLY | 3,989,976 5.600% | 3,989,976 (New Position) | Filing History |
| 2021-02-12 4:50 pm Purchase | 2020-12-31 | 13G | AC Immune S.A. ACIU | ELI LILLY & Co LLY | 3,615,328 5.000% | 3,615,328 (New Position) | Filing History |
| 2021-02-12 4:43 pm Purchase | 2020-12-31 | 13G | Avidity Biosciences, Inc. RNA | ELI LILLY & Co LLY | 2,319,396 6.200% | 2,319,396 (New Position) | Filing History |
| 2021-02-12 4:31 pm Purchase | 2020-12-31 | 13G | Sigilon Therapeutics, Inc. SGTX | ELI LILLY & Co LLY | 211,111 8.800% | 211,111 (New Position) | Filing History |
| 2021-02-12 08:44 am Sale | 2020-12-31 | 13G | Eli Lilly and Company LLY | PNC FINANCIAL SERVICES GROUP INC. PNC | 52,012,151 5.440% | -118,501 (-0.23%) | Filing History |
| 2021-02-10 10:52 am Sale | 2020-12-31 | 13G | Eli Lilly and Company LLY | The Vanguard Group | 68,661,494 7.180% | -2,258,556 (-3.18%) | Filing History |
| 2021-01-29 09:57 am Sale | 2020-12-31 | 13G | Eli Lilly and Company LLY | BlackRock Inc. BLK | 58,811,768 6.100% | -2,067,444 (-3.40%) | Filing History |
| 2021-01-21 2:30 pm Sale | 2020-12-31 | 13G | Eli Lilly and Company LLY | LILLY ENDOWMENT INC | 111,132,343 11.620% | -3,428,256 (-2.99%) | Filing History |
| 2021-01-08 06:04 am Purchase | 2021-01-06 | 13G | Precision BioSciences, Inc. DTIL | ELI LILLY & Co LLY | 125,406 7.165% | 125,406 (New Position) | Filing History |